Logo image
New search Researchers Research units
Sign in
Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma
Journal article   Open access   Peer reviewed

Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma

Dorothy Benton, Hoi Yee Chow, Sofiia Karchugina and Jonathan Chernoff
PloS one, v 19(7), pe0305121
31 Jul 2024
PMID: 39083549
url
https://doi.org/10.1371/journal.pone.0305121View
Published, Version of Record (VoR) Open

Abstract

Adaptor Proteins, Signal Transducing - genetics Adaptor Proteins, Signal Transducing - metabolism Apoptosis - drug effects Cell Line, Tumor Cell Proliferation - drug effects DNA-Binding Proteins - genetics DNA-Binding Proteins - metabolism Drug Synergism Hippo Signaling Pathway Humans Neurilemmoma - genetics Neurilemmoma - metabolism Neurilemmoma - pathology Neurofibromatosis 2 - genetics Neurofibromatosis 2 - metabolism Neurofibromin 2 - deficiency Neurofibromin 2 - genetics Neurofibromin 2 - metabolism p21-Activated Kinases - antagonists & inhibitors p21-Activated Kinases - genetics p21-Activated Kinases - metabolism Protein Kinase Inhibitors - pharmacology Protein Serine-Threonine Kinases - antagonists & inhibitors Protein Serine-Threonine Kinases - genetics Protein Serine-Threonine Kinases - metabolism Signal Transduction - drug effects Transcription Factors - genetics Transcription Factors - metabolism YAP-Signaling Proteins - genetics YAP-Signaling Proteins - metabolism

Metrics

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Oncology
Logo image